flow trial semaglutide kidney outcomes 2024 nejm hazard ratio 0.76 clinical (funded by Novo Nordisk) The FLOW trial for semaglutide
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1




























